ALKS vs CORT: stock comparison and AI forecast
Alkermes Plc. (ALKS) and Corcept Therapeutics Inc (CORT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALKS Alkermes Plc.
- Price
- $44.54 +25.8% · 6M
- Market Cap
- $7.47B
- P/E Ratio
- 43.2x
- Size
- mid-cap
- AI Forecast
CORT Corcept Therapeutics Inc
- Market Cap
- $7.74B
- P/E Ratio
- 42.9x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ALKS and CORT have similar market capitalizations ($7.47B and $7.74B).
- CORT trades at 42.9 times trailing earnings, ALKS at 43.2 times.
- CORT turns 16.8% of its revenue into net income, against -0.0% for ALKS.
- ALKS carries 1.38 times debt per unit of equity, against 0.24 times for CORT.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALKS | CORT |
|---|---|---|
| Market Cap | $7.47B | $7.74B |
| P/E Ratio | 43.24x | 42.89x |
| P/B Ratio | 4.01x | 9.29x |
| EPS | $1.03 | $1.67 |
| Book Value/Share | $11.12 | $7.71 |
| Revenue/Share | $10.45 | $8.91 |
| FCF/Share | $1.36 | $1.80 |
Profitability & Margins
| Metric | ALKS | CORT |
|---|---|---|
| ROE | -0.0% | 19.5% |
| ROA | -0.0% | 15.7% |
| ROIC | 1.7% | 12.9% |
| Gross Margin | 82.9% | 98.5% |
| Operating Margin | 3.7% | 11.5% |
| Net Margin | -0.0% | 16.8% |
| EBT Margin | 0.7% | 13.5% |
| Tax Rate | 103.1% | -23.7% |
Financial Health
| Metric | ALKS | CORT |
|---|---|---|
| Current Ratio | 2.42x | 3.00x |
| Quick Ratio | 2.02x | 2.94x |
| D/E Ratio | 1.38x | 0.24x |
| Financial Leverage | 2.38x | 1.24x |
| Interest Coverage | 14.7x | – |
| Working Capital | $929M | $356M |
Cash Flow
| Metric | ALKS | CORT |
|---|---|---|
| Operating Cash Flow | $243M | $198M |
| Free Cash Flow | $227M | $195M |
| Capital Spending | -$16M | -$3M |
| OCF Growth YoY | -55.1% | 21.6% |
| FCF Growth YoY | -53.7% | 19.7% |
| FCF/Sales | 13.0% | 20.2% |
| CapEx/Sales | 0.9% | 0.4% |
Operational Efficiency
| Metric | ALKS | CORT |
|---|---|---|
| Asset Turnover | 0.40x | 0.93x |
| Receivables Turnover | 3.8x | 8.7x |
| Inventory Turnover | 1.1x | 1.2x |
| Fixed Assets Turnover | 8.2x | 195.1x |
| Days Sales Outstanding | 96 days | 42 days |
| Days Inventory | 318 days | 308 days |
| Payables Period | 131 days | 568 days |
| Cash Conversion Cycle | 282 days | -217 days |
Income Statement
| Metric | ALKS | CORT |
|---|---|---|
| Total Revenue | $1.75B | $964M |
| Operating Income | $64M | $111M |
| Net Income | -$350K | $162M |
| R&D Expense | $430M | $242M |
| SG&A Expense | $878M | $597M |
| Cost of Goods Sold | $300M | $14M |
Dividend & Shareholder Information
| Metric | ALKS | CORT |
|---|---|---|
| Shares Outstanding | 168M | 108M |
| Net Income Growth | -100.1% | 53.0% |
| EPS Growth | -51.2% | 70.4% |
ALKS vs CORT: stock comparison and AI forecast
Which is bigger, ALKS or CORT?
ALKS and CORT have similar market capitalizations ($7.47B and $7.74B).
Which is cheaper on earnings, ALKS or CORT?
CORT trades at 42.9 times trailing earnings, ALKS at 43.2 times.
Which one does Intratio's AI model rank higher, ALKS or CORT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.